Scarica l'app Stockscreener
100.52
2.20%
-2.26
Pre-mercato:
100.01
-0.51
-0.51%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$102.78
Aprire:
$102.83
Volume 24 ore:
758.11K
Relative Volume:
0.87
Capitalizzazione di mercato:
$6.90B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
16.73
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
+0.36%
1M Prestazione:
-0.57%
6M Prestazione:
-10.65%
1 anno Prestazione:
+62.84%
Intervallo 1D:
$99.21
$103.71
Intervallo di 1 settimana:
$93.88
$104.00
Portata 52W:
$61.46
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Confronta LNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
100.52 | 6.90B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
146.76 | 65.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.65 | 46.11B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.85B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.43 | 15.39B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
285.19 | 12.81B | 2.76B | 1.11B | 898.10M | 22.77 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights By Investing.com - Investing.com India
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - The Globe and Mail
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights - Investing.com India
Lantheus Closes Evergreen Theragnostics Acquisition - MarketScreener
Lantheus Completes Acquisition of Evergreen Theragnostics - TipRanks
Lantheus completes acquisition of Evergreen Theragnostics - TipRanks
Lantheus bolsters radiopharmaceutical portfolio with acquisition - Investing.com
Major Radiopharmaceutical Deal: Lantheus Acquires Evergreen, Gains Revenue-Generating Assets - Stock Titan
How To Trade (LNTH) - news.stocktradersdaily.com
Lobbying Update: $420,000 of LANTHEUS HOLDINGS INC. lobbying was just disclosed - Nasdaq
Q4 Earnings Review: Medical Devices & SuppliesImaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC) - The Globe and Mail
CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment - Yahoo Finance
Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH) - Yahoo Finance
Lantheus Holdings: One Blockbuster, Evolving Pipeline (NASDAQ:LNTH) - Seeking Alpha
Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock? - simplywall.st
How to Take Advantage of moves in (LNTH) - Stock Traders Daily
Insider Sell: Marshall Robert J. Jr. Sells 10,000 Shares of Lant - GuruFocus.com
Lantheus price target lowered to $122 from $127 at B. Riley - TipRanks
B. Riley Cuts Price Target on Lantheus Holdings to $122 From $127, Keeps Buy Rating - Marketscreener.com
Lantheus Holdings CFO Marshall sells $1.01 million in stock By Investing.com - Investing.com Australia
Lantheus Holdings CFO Marshall sells $1.01 million in stock - Investing.com
Commit To Buy Lantheus Holdings At $75, Earn 14.4% Using Options - Nasdaq
Is Lantheus Holdings, Inc. (LNTH) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey
Jones Financial Companies Lllp Acquires 1,182 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus Holdings’ SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
10 Best Healthcare Stocks For Long-Term Investment - Insider Monkey
Lantheus Holdings’ SWOT analysis: stock poised for growth amid challenges - Investing.com India
Charles Schwab Investment Management Inc. Reduces Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus at Leerink Global Healthcare Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Lantheus at Leerink Global Healthcare Conference: Strategic Growth Plans - Investing.com
Earnings To Watch: Lantheus Holdings Inc (LNTH) Reports Q4 2024 Result - GuruFocus.com
Trading (LNTH) With Integrated Risk Controls - Stock Traders Daily
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives $132.86 Consensus Price Target from Analysts - Defense World
Lantheus Holdings president Paul Blanchfield sells $204,232 in stock - Investing.com Australia
Lantheus Holdings president Paul Blanchfield sells $204,232 in stock By Investing.com - Investing.com UK
Lantheus Holdings: Pylarify Makes Bull Case Despite Looming Patent Expiry (LNTH) - Seeking Alpha
Why Lantheus Holdings Stock Got Thrashed on Tuesday - AOL
Lantheus at TD Cowen Conference: Strategic Growth in Radiopharmaceuticals By Investing.com - Investing.com Canada
Lantheus at TD Cowen Conference: Strategic Growth in Radiopharmaceuticals - Investing.com
Lantheus Holdings director sells $5 million in stock - Investing.com
Lantheus Holdings' (NASDAQ:LNTH) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
IFP Advisors Inc Sells 9,598 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Why Lantheus Shares Are Facing a Downturn - TipRanks
Lantheus Holdings (NasdaqGM:LNTH) Sees 19% Surge Following 2024 Earnings US$1.534 Billion Sales Increase - Yahoo Finance
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
4.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):